US Politics
Trump Administration Secures Historic Price Reductions for Obesity Medications
President Trump announced a deal with drugmakers Novo Nordisk and Eli Lilly to significantly reduce prices of obesity medications, expanding access for millions of Americans. This groundbreaking move demonstrates how market-driven solutions can empower citizens to take control of their health while preserving individual liberty and choice.
